Xenon Pharmaceuticals Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenon Pharmaceuticals Inc. on March 9, 2017. The report pertains to the announcement of the 2017 annual meeting of shareholders, including the meeting date, record date, and related information.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notification of a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing solely addresses the scheduling of the annual shareholder meeting.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, risk factors, contingencies, or discussion of unusual items. It references a separate filing submitted to the System for Electronic Document Analysis and Retrieval (SEDAR) in Canada for full details regarding the shareholder meeting.
Key Facts for Investors to Verify
- The specific date, time, and location of the 2017 annual meeting of shareholders.
- The record date for determining shareholders eligible to vote at the meeting.
- Details of the matters to be voted upon, as contained in the referenced SEDAR filing (Exhibit 99.1).